<code id='14E5C25BA9'></code><style id='14E5C25BA9'></style>
    • <acronym id='14E5C25BA9'></acronym>
      <center id='14E5C25BA9'><center id='14E5C25BA9'><tfoot id='14E5C25BA9'></tfoot></center><abbr id='14E5C25BA9'><dir id='14E5C25BA9'><tfoot id='14E5C25BA9'></tfoot><noframes id='14E5C25BA9'>

    • <optgroup id='14E5C25BA9'><strike id='14E5C25BA9'><sup id='14E5C25BA9'></sup></strike><code id='14E5C25BA9'></code></optgroup>
        1. <b id='14E5C25BA9'><label id='14E5C25BA9'><select id='14E5C25BA9'><dt id='14E5C25BA9'><span id='14E5C25BA9'></span></dt></select></label></b><u id='14E5C25BA9'></u>
          <i id='14E5C25BA9'><strike id='14E5C25BA9'><tt id='14E5C25BA9'><pre id='14E5C25BA9'></pre></tt></strike></i>

          Home / hotspot / comprehensive

          comprehensive


          comprehensive

          author:fashion    Page View:22
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In